Interestingly, the highest levels of DHODH expression were observed in high-risk, MYCN-amplified tumors (Figure 1E), and DHODH expression increased with International Neuroblastoma Staging System (INSS) stage (Supplemental Figure 1C). The gene discussed is MYCN; the disease is neuroblastoma.